Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06366373

Reducing Stigma Through a Mental Health Art Exhibition and Its Printed Brochure

Mental health art exhibitions, as an intervention strategy integrating artistic expression and social contact, have the potential to positively impact the elimination of stigma and discrimination associated with mental health problems. Based on a two-phase experimental design, this study aims to evaluate the effect of a real-world mental health art exhibition (Phase One) and its printed brochure (Phase Two) on stigma/discrimination and related outcomes, such as mental health literacy. The evaluation will encompass three categories of people: those with lived experience of mental disorders, family members and friends of those with lived experience, and the general public. Qualitative methods, such as in-depth interviews, will also be used for the evaluation.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Qixi Charity, Wuhan, Hubei, China

Loading trial locations.

About this study

Mental health art exhibitions, as an intervention strategy integrating artistic expression and social contact, have the potential to positively impact the elimination of stigma and discrimination associated with mental health problems. Based on a two-phase experimental design, this study aims to evaluate the effect of a real-world mental health art exhibition (Phase One) and its printed brochure (Phase Two) on stigma/discrimination and related outcomes, such as mental health literacy. The evaluation will encompass three categories of people: those with lived experience of mental disorders, family members and friends of those with lived experience, and the general public. Qualitative methods, such as in-depth interviews, will also be used for the evaluation.

The intervention measure is the Second Mental Health Art Science Exhibition scheduled to take place in Wuhan, China from April 27 to May 14, 2024. Organized by "Qixi Charity", an NGO led by individuals with lived experience of mental disorders, as well as their family members and friends, the exhibition will feature offline artworks created by these individuals and other contributors. The exhibited artworks aim to reflect the diverse dimensions of mental health and ill-health.

At Phase One, the effect of the real-world exhibition is evaluated through a single-arm pre-post study design. The adult audience, who are individuals with lived experience of mental disorders, or family members and friends of those with lived experience, or the general public, will be recruited as the experimental group, and they will be surveyed three times: (1) a baseline survey before the interventions (T0); (2) a follow-up survey in the first month after the interventions (T1); (3) a follow-up survey in the sixth month after the interventions (T2). Additionally, the study will perform text analysis of media reports and social media discussions related to the exhibition to supplement the assessment of its social impact.

Due to the high costs and limited feasibility of widespread implementation of the real-world Mental Health Art Exhibition, the intervention was then adapted to a printed exhibition brochure. At Phase Two, the effect of the brochure intervention in reducing stigma and other related outcomes will be assessed and compared with a traditional health education brochure and a postcard as a placebo. Individuals with lived experience of mental disorders, or family members and friends of those with lived experience, or the general public, who do not visit the exhibition of Phase One, will be recurited. After that, individuals with lived experience of mental disorders and their family members or friends will be cluster-randomized to either the exhibition brochure group or the control group (the latter typically receives or seeks out traditional health education materials during healthcare visits). As for the general public will be cluster-randomized into three groups: (1) the exhibition brochure group, (2) the traditional health education brochure group, and (3) the control group. Effectiveness will be evaluated through three surveys: (1) a baseline survey before the interventions (T0); (2) a follow-up survey one month after the interventions (T1); and (3) a follow-up survey six months after the interventions (T2).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

General Inclusion Criteria:

  • Adults aged 18 and above

General Exclusion Criteria:

  • Individuals who are unable to understand the content of the questionnaire due to illness and other factors
  • Mental health professionals, including psychiatrists, psychologists, nurses, social workers and medical students

Additional Inclusion Criteria for Phase One:

  • Individuals who attend the exhibition offline

Additional Inclusion Criteria for Phase Two:

  • Individuals who did not visit the exhibition of Phase One

Treatment and study plan

A mental health art exhibition

Other

The specific intervention measure is the Second Mental Health Art Science Exhibition scheduled to take place in Wuhan, China from April 27 to May 27, 2024. Organized by "Qixi Charity", an NGO led by individuals with lived experience of mental disorders, as well as their family members and friends, the exhibition will feature offline artworks created by these individuals and other contributors. The exhibited artworks aim to reflect the diverse dimensions of mental health and ill-health.

printed or online education materials

Other

The specific intervention measure is to provide printed or online education materials within the first month after the baseline survey

Primary outcomes

  1. Stigma/discrimination regarding mental disorders

    Time frame: Time point 0: before the exhibition; Time point 1: within the first month after the exhibition; Time point 2: the sixth month after the exhibition

    Individuals with lived experience of mental disorders: internalized stigma of mental illness scale (ISMI-29), the perceived devaluation discrimination scale (PDD-12) Family members and friends of those with lived experience: affiliate stigma scale (ASS-22), the perceived devaluation discrimination scale (PDD-12) The general public: community attitudes toward mental ill scale (CAMI-20), attribution questionnaire (AQ-9), the perceived devaluation discrimination scale (PDD-12)

Secondary outcomes

  1. mental health literacy

    Time frame: Time point 0: before the exhibition; Time point 1: within the first month after the exhibition; Time point 2: the sixth month after the exhibition

    All participants: mental health and care knowledge questionnaire (MHCK-16)

Other outcomes

  1. Willingness to pay

    Time frame: T2: six months after the interventions (T2)

    Individuals with lived experience of mental disorders & family members and friends of those with lived experience: maximum and minimum amount of money willing to pay for treating the suffering mental health conditions The general public: maximum and minimum amount of money willing to pay for treating 2 mental health conditions and 2 general health conditions in vignettes

Study contacts

Contact information is provided by the study sponsor or research team.

Wei Zhou, Ph.D.

CONTACT

[email protected]

86-15874085133

Sponsors and collaborators

Lead sponsor

Hunan University

Other

Collaborators

  • Central South University
  • Qixi Charity

Registry information

Official study title

Reducing Stigma Through a Mental Health Art Exhibition and Its Printed Brochure: an Social-contact Intervention Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 15, 2024
Registry last updated
Jan 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.